What is Lifecore Biomedical, Inc.'s revenue?

Lifecore Biomedical, Inc. (LFCR) generated $125.9M in revenue over the trailing twelve months, down 3.8% year over year.

Is Lifecore Biomedical, Inc. profitable?

Lifecore Biomedical, Inc. is not currently profitable: it reported a net loss of $40.9M over the trailing twelve months, a -30.0% net margin.

What are Lifecore Biomedical, Inc.'s profit margins?

Gross margin is 31.3% and operating margin is -14.5%, with a -30.0% net margin.

What is Lifecore Biomedical, Inc.'s earnings per share?

Lifecore Biomedical, Inc.'s diluted EPS over the trailing twelve months is $-1.17.

Where does Lifecore Biomedical, Inc.'s income statement data come from?

Every line is extracted from Lifecore Biomedical, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Lifecore Biomedical, Inc. LFCR Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY

Simplified Detailed

	FY'25	FY'24	FY'23
Total revenue	$128.87M+0.5%	$128.26M+24.2%	$103.27M-7.2%
Total cost of revenue	$88.57M+2.5%	$86.41M+14.8%	$75.29M+10.4%
Gross profit	$40.3M-3.7%	$41.85M+49.5%	$27.99M-28.4%
Gross margin	31.3%-1.4pp	32.6%+5.5pp	27.1%-8.0pp
Research and development	$8.26M-3.7%	$8.58M-1.9%	$8.74M+12.9%
Selling, general and administrative	$44.86M+10.5%	$40.61M+4.2%	$38.97M+17.5%
Operating income	——	——	-$21.8M-71.8%
Interest expense	——	——	$15.66M+9.9%
Interest income	——	——	$68K-16.0%
Other income (expense), net	——	-$3.05M-163%	-$1.16M-248%
Income before income taxes	-$38.67M—	——	-$63.93M-216%
Income tax expense	$43K—	——	$308K+106%
Net income	-$38.72M—	——	-$99.56M+14.7%
Net margin	-30%—	——	-96.4%+8.5pp
Preferred stock dividends	$3.32M—	——	——
Diluted earnings per share	-$1.23—	——	-$3.32+16.4%
Basic earnings per share	-$1.23—	——	-$3.32+16.4%
Weighted-average shares, diluted	137.1M-2.2%	140.1M+17.3%	119.5M+1.4%
Weighted-average shares, basic	137.1M+12.5%	121.8M+2.0%	119.5M+1.4%
Fair Value Measurement With Unobservable Inputs Reconciliation Recurring Basis Liability Gain Loss Included In Earnings	——	$41.9M—	$0—
Gain (Loss) On Disposition Of Assets, Net Of Cost Of Sales	——	——	——
Accounts payable	——	-$6.68M-141%	$16.44M—
Increase (Decrease) in Inventories	-$7.69M—	——	$13.45M—
Cash Provided by (Used in) Financing Activity, Including Discontinued Operation	$6.83M—	——	$39.7M—
Cash Provided by (Used in) Investing Activity, Including Discontinued Operation	-$6.42M+65.1%	-$18.4M-552%	-$2.82M—
Cash Provided by (Used in) Operating Activity, Including Discontinued Operation	——	$257K+101%	-$19.43M+18.7%
Other Noncash Income (Expense)	——	-$1.83M—	——
Other income, net (Note 6)	——	-$3.05M-163%	-$1.16M-248%
Payment, Tax Withholding, Share-Based Payment Arrangement	$1.27M+736%	$152K-44.5%	$274K-65.3%
Payments to Acquire Property, Plant, and Equipment	$13.42M-27.1%	$18.4M—	——
Dispositions of property, plant, and equipment	——	——	$0-100%
Stock-based compensation	$10.16M+63.8%	$6.2M+71.7%	$3.61M+38.5%
Temporary Equity, Accretion to Redemption Value, Adjustment	$192K—	——	——
EBIT	-$23.69M—	——	-$21.8M-71.8%
EBITDA	-$15.66M—	——	-$8.62M-260%
EBITDA	-$15.66M—	——	-$8.62M-260%
EBITDA margin	-12.2%—	——	-8.3%-13.2pp
EBIT	-$23.69M—	——	-$21.8M-71.8%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Lifecore Biomedical, Inc..

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Lifecore Biomedical, Inc.'s revenue?: Lifecore Biomedical, Inc. (LFCR) generated $125.9M in revenue over the trailing twelve months, down 3.8% year over year.
Is Lifecore Biomedical, Inc. profitable?: Lifecore Biomedical, Inc. is not currently profitable: it reported a net loss of $40.9M over the trailing twelve months, a -30.0% net margin.
What are Lifecore Biomedical, Inc.'s profit margins?: Gross margin is 31.3% and operating margin is -14.5%, with a -30.0% net margin.
What is Lifecore Biomedical, Inc.'s earnings per share?: Lifecore Biomedical, Inc.'s diluted EPS over the trailing twelve months is $-1.17.
Where does Lifecore Biomedical, Inc.'s income statement data come from?: Every line is extracted from Lifecore Biomedical, Inc.'s SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.